Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-19

Clinical Trial Update: Enhancing Telemedicine for T2D [NA]

View source ↗

Summary

This clinical trial update reports a University of Pittsburgh study to enhance telemedicine for Type 2 diabetes, with the study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pittsburgh | Conditions: Type 2 Diabetes | NA | Status: RECRUITING